An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT06693973 · RECRUITING

Trial details

NCT number

NCT06693973

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Status

RECRUITING

Phase

Early Phase 1

Study type

INTERVENTIONAL

Start date

2023-12-27

Primary completion

2026-01-13

Enrollment

13

View on ClinicalTrials.gov